Company release, inside information,
THE INFORMATION CONTAINED IN THIS RELEASE IS NOT FOR PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO
Due to strong demand, the board of directors of the Company resolved to increase the aggregate gross proceeds raised in the Placing to approximately
The subscription price of the Placing Shares is
The Placing was carried out based on offers received in an accelerated bookbuilding and based on the authorisation given by the Company's annual general meeting to the board of directors on
Subject to the completion of the Placing, the Placing Shares (ISIN code FI4000087861) will be registered with the trade register maintained by the Finnish Patent and Registration Office and will be issued in the book-entry system on or about
The Placing Shares are expected to be ready for delivery to the investors against payment through
Herantis intends to make applications for the admission into trading of the Placing Shares on Nasdaq First North Growth Market Finland and on Nasdaq First North Growth Market Sweden. Trading in the Placing Shares is expected to commence on Nasdaq First North Growth Market Finland and Nasdaq First North Growth Market Sweden on or about
The CEO of Herantis,
"I am very pleased with the result of the Placing. With the Company poised for important next steps forward in both pillars of its pipeline, the net proceeds of the Placing are expected to help the Company in the next phase of development toward the eventual objective of reaching commercialisation."
Carnegie is acting as the sole global coordinator and sole bookrunner of the Placing.
Board of directors
Further information:
Company web site: www.herantis.com (https://www.globenewswire.com/Tracker?data=LCBxfl0hdH3boek_08iY6t_U6w701MBIIRLPbWTHcCfMSPMcHILU-qmA4foOOtvEH5IbS68uG3mnOxP29Gv89w==)
Certified Advisor:
About
Important notice
Not for publication or distribution, directly or indirectly, in or into
This release is not a prospectus and not an offer relating to securities. No offer will be made in any such jurisdiction in which the offer or participation therein would be unlawful. No offer will be made in any such jurisdiction in which the offer would require the preparation of a prospectus, registration or any other similar action. The sole global coordinator and sole bookrunner is acting exclusively for the Company and no one else connected to the possible share issue. The sole global coordinator and sole bookrunner will not be responsible to anyone other than the Company for providing the protections afforded to its clients nor for giving advice in relation to the contents of this release or the possible transaction pursuant to this release.
This release is directed only to (A) persons who are outside
This release does not constitute an offer for sale of securities in
This release contains forward-looking statements. These forward-looking statements are not based on historical facts, but are statements about future expectations. Statements included in this release which contain expressions "considers", "aims", "anticipates", "assumes", "believes", "estimates", "expects", "intends", "may", "plans", "should", and other similar expressions related to the Company or the possible share issue are examples of such forward-looking statements. Other forward-looking statements can be identified in the context in which the statements are made. Forward-looking statements contain information about future results, plans or expectations regarding the Company's business operations, including its strategy and growth plans and profitability, and the general economic situation. These forward-looking statements are based on current plans, estimates, prospects and expectations. They are based on certain currently valid expectations that may however turn out to be wrong. These forward-looking statements are based on assumptions and they contain several risks and uncertainties. Investors should not rely on these forward-looking statements. Several factors may result in a material deviation of the Company's actual business outcome or financial standing from the business outcome or financial standing that is indicated or referred to in forward-looking statements. The absence or occurrence of the aforementioned factors may cause a substantial deviation of the Company's actual business outcome or financial standing from what is directly or indirectly presented or described in the sections, which include forward-looking statements. Because of risks, uncertainties, assumptions and other factors, events described in forward-looking statements may not necessarily occur. Therefore, the accuracy and completeness or the occurrence of the predicted events of the forward-looking statements presented in this release cannot be guaranteed.
https://news.cision.com/herantis-pharma-oyj/r/herantis-pharma-plc-to-raise-eur-6-8-million-as-a-result-of-the-directed-offering,c3120633
(c) 2020 Cision. All rights reserved., source